Loading...
New Strategies in Bladder Cancer: A Second Coming for Immunotherapy
Urothelial bladder cancer (UBC) remains one of the most common and deadly cancers worldwide, and platinum based chemotherapy, which has been the standard of care in metastatic bladder cancer, has had limited success in improving outcomes for patients. The recent development and translation of therap...
Na minha lista:
| Udgivet i: | Clin Cancer Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4825862/ https://ncbi.nlm.nih.gov/pubmed/26683632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-1135 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|